US Broker Ratings

Biogen Inc. (BIIB) Stock Analysis: Evaluating the 7.22% Upside Potential Amidst Market Dynamics

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector specializing in drug manufacturing, currently presents a noteworthy opportunity for investors, with its potential upside..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unlocking a 21.53% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approaches to drug..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Robust Analyst Ratings Signal Potential 51.69% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, is drawing significant attention from investors. Specializing in rare neuroendocrine diseases, Rhythm Pharmaceuticals..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Growth Amidst Challenges

Investors eyeing Centene Corporation (NYSE: CNC) may find themselves intrigued by the company’s substantial market presence in the healthcare sector, yet wary of its current valuation..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Analyst Consensus and 12% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has drawn attention from investors with its strong portfolio of over-the-counter (OTC) health..

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector focusing on medical instruments and supplies, presents a captivating investment opportunity with a notable potential..

BioNTech SE (BNTX) Investor Outlook: Analyzing a 25.91% Potential Upside Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX) stands as a beacon in the biotechnology industry, particularly known for its contributions to immunotherapy for cancer and infectious diseases. The German-based..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI) stands at the forefront of the healthcare industry with its innovative medical devices and patient monitoring technologies. Based in Irvine, California, Masimo..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 83% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently caught the attention of investors, with an impressive potential upside of 83.19% as indicated by analyst target prices. This..

Integer Holdings Corporation (ITGR) Stock Report: Evaluating Growth Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity for those eyeing..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 50.49% Potential Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents an intriguing opportunity. With a market capitalization of $12.89 billion,..

Natera, Inc. (NTRA) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA), a pioneering player in the diagnostics and research sector, presents an intriguing opportunity for investors seeking growth in the healthcare industry. With..

ADMA Biologics Inc (ADMA) Stock Analysis: Riding the Wave of a 64.85% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) is a noteworthy player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.72 billion, this..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 7.41% Upside in the Healthcare Sector

As an investor in the healthcare sector, keeping an eye on Alcon Inc. (ALC) could be a prudent move. With a market capitalization of $43.58 billion,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 15.60% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is capturing investor attention with its promising portfolio of RNA-targeted therapies and a potential..

Waters Corporation (WAT) Investor Outlook: Evaluating a Potential 24.63% Upside

Waters Corporation (NYSE: WAT), a leader in the healthcare sector’s diagnostics and research industry, is making waves with its analytical workflow solutions across Asia, the Americas,..

Waystar Holding Corp. (WAY) Stock Analysis: Capitalize on a 44.25% Potential Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY) is steadily positioning itself as a significant player in the healthcare technology arena, offering a compelling investment opportunity for those keen..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 32% Potential Upside in the Healthcare Sector

IQVIA Holdings, Inc. (IQV) is proving to be a compelling investment opportunity within the healthcare sector, boasting a significant potential upside of 32.12% according to the..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a stalwart in the healthcare sector, is capturing investor attention with its robust portfolio of diagnostic and therapeutic products. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds